Galectin Therapeutics Inc. (GALT) earnings
GALT earnings moved a median of +1.72% by the close. Quarterly and annual GALT reports and results, each read against the price at its own news timestamp. Back to the GALT overview →
12 measured GALT earnings events.
Where these GALT earnings landedvs 12 measured GALT earnings reactions
| Middle 50% of GALT earnings reactions | -4.67% to +6.61% |
|---|---|
| Median reaction (to close) | +1.72% |
| Measured reactions | 12 |
Point-in-time · zero look-ahead
Half of the 12 GALT earnings events with a measured close landed between -4.67% and +6.61%; 58% closed up.
| Date | Headline | Event | 5-min | To close |
|---|---|---|---|---|
| Form 10-Q GALECTIN THERAPEUTICS For: Jun 30 | SEC filing · Form 10-Q | -4.57% | -1.71% | |
| Form 10-Q GALECTIN THERAPEUTICS For: Mar 31 | SEC filing · Form 10-Q | -1.91% | -8.05% | |
| Form 10-K GALECTIN THERAPEUTICS For: Dec 31 | SEC filing · Form 10-K | +2.35% | +9.41% | |
| Form 10-Q GALECTIN THERAPEUTICS For: Sep 30 | SEC filing · Form 10-Q | +2.94% | +8.04% | |
| Form 10-Q GALECTIN THERAPEUTICS For: Jun 30 | SEC filing · Form 10-Q | +1.90% | +1.90% | |
| Form 10-Q GALECTIN THERAPEUTICS For: Mar 31 | SEC filing · Form 10-Q | +0.00% | +1.54% | |
| Form 10-K GALECTIN THERAPEUTICS For: Dec 31 | SEC filing · Form 10-K | -10.64% | -13.47% | |
| Form 10-Q GALECTIN THERAPEUTICS For: Sep 30 | SEC filing · Form 10-Q | +0.00% | -3.85% | |
| Form 10-Q GALECTIN THERAPEUTICS For: Jun 30 | SEC filing · Form 10-Q | +0.00% | +6.13% | |
| Form 10-Q GALECTIN THERAPEUTICS For: Mar 31 | SEC filing · Form 10-Q | +3.60% | +10.07% | |
| Form 10-K GALECTIN THERAPEUTICS For: Dec 31 | SEC filing · Form 10-K | -5.44% | +2.09% | |
| Form 10-Q GALECTIN THERAPEUTICS For: Sep 30 | SEC filing · Form 10-Q | -4.29% | -7.14% |
Keep exploring
More GALT: analyst actions → · SEC filings → · GALT overview →
Other Healthcare names and their earnings
| Ticker | Events | Median 30-min | % positive |
|---|---|---|---|
| NeuroOne Medical Technologies Corporation (NMTC) | 310 | -0.19% | 41% |
| SI-BONE, Inc. (SIBN) | 310 | +0.14% | 56% |
| MENLO THERAPEUTICS INC COMMON (MNLO) | 308 | 0.00% | 49% |
| Syros Pharmaceuticals, Inc. (SYRS) | 307 | +0.51% | 55% |
Same sector, same measurement: percent move vs. the price at the news timestamp, read at 30 minutes. Sample sizes differ, so the medians are comparable but the confidence behind them is not. These are each name’s all-news baseline, not its earnings — that is what the link opens.